SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-085740
Filing Date
2021-06-25
Accepted
2021-06-25 16:30:40
Documents
6
Group Members
KNIGHT MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2120577d1_sc13d.htm SC 13D 87511
2 EXHIBIT 99.2 tm2120577d1_ex99-2.htm EX-99.2 34197
3 EXHIBIT 99.3 tm2120577d1_ex99-3.htm EX-99.3 33211
4 GRAPHIC tm2120577d1_ex99-3img01.jpg GRAPHIC 4100
5 EXHIBIT 99.4 tm2120577d1_ex99-4.htm EX-99.4 15538
6 EXHIBIT 99.5 tm2120577d1_ex99-5.htm EX-99.5 8053
  Complete submission text file 0001104659-21-085740.txt   185867
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Subject) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87768 | Film No.: 211048304
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filed by) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations